세계의 견관절경 검사 시장 : 제품 유형별, 증상별, 최종사용자별 - 기회 분석 및 산업 예측(2023-2032년)

Shoulder Arthroscopy Market By Product Type, By Indication, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

US $ 5,730 ￦ 7,891,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 9,600 ￦ 13,221,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

세계 견관절경 검사 시장 규모는 2022년 4억 3,246만 달러로, 2023-2032년 CAGR 5.1%로 2032년에는 7억 1,212만 달러에 달할 것으로 예상됩니다. 견관절경 검사는 관절경이라는 소형 카메라를 이용해 견관절의 영상을 비디오 스크린에 비추는 외래 환자 시술입니다.

이후 의료진은 이 영상을 통해 어깨의 손상 부위를 진단하고, 작은 수술기구를 사용하여 어깨를 복원하고 어깨의 운동성을 회복시킵니다. 이 수술은 최소 침습적이며 절개창이 작습니다. 절개 부위의 크기는 열쇠구멍 정도입니다. 수술은 몇 주에서 몇 달이 걸리지만 환자는 당일 퇴원할 수 있습니다. 견관절경을 통해 의료진은 물리치료, 약물치료, 주사, 휴식 등 다른 비수술적 치료에 반응하지 않는 어깨 통증을 치료할 수 있습니다.

견관절경 검사는 염증을 일으키는 조직을 제거하는 데 사용됩니다. 따라서 이두근 힘줄 손상, 골극, 오십견, 관절와순 파열, 견갑골 주변 조직 손상, 골관절염, 회전근개 파열, 회전근개 파열, 회전근개 건염, 어깨 충돌 증후군, 견관절이 풀리거나 빠지는 견관절 불안정성 등의 부상을 치료하는 데 사용됩니다. 견관절경 수술은 무릎 수술에 이어 두 번째로 많이 시행되는 정형외과 수술입니다. 그러나 견관절경 수술의 가장 일반적인 유형은 회전근개 수술입니다. 이 시장의 성장은 수술 건수의 증가로 인해 장비에 대한 수요가 급증하고 있기 때문입니다.

견관절 손상 발생률 증가, 관절경 기술의 발전, 인구 고령화, 최소 침습 수술에 대한 선호도가 견관절경 시장의 성장을 촉진하는 주요 요인입니다. 견관절경 수술의 주요 원인 중 하나는 회전근개 파열, 관절와순 파열, 어깨 충돌과 같은 어깨 부상의 발생률 증가입니다. 스포츠 부상과 노화에 따른 마모도 견관절경 수술의 증가에 한 몫을 하고 있습니다.

그러나 높은 수술 비용, 전문 시설에 대한 접근성 제한, 대체 치료와의 경쟁은 시장 성장을 저해하는 요인으로 작용할 수 있습니다. 견관절경 수술은 비용이 많이 들기 때문에 일부 환자들이 수술을 받는 것을 주저할 수 있습니다. 또한, 의료 서비스 제공자에게는 상환 문제를 야기할 수 있습니다. 이는 어느 정도 시장 성장을 저해할 수 있습니다.

견관절경 시장은 제품 유형, 증상, 최종사용자, 지역으로 분류됩니다. 제품 유형에 따라 시장은 관절경, 파워 쉐이버 시스템, 관절경 임플란트, 관절경 시스템, 기타로 분류됩니다. 증상별로는 회전근개 파열, 견관절 불안정증, 오십견, 어깨 충돌 증후군, 기타로 분류됩니다. 최종사용자에 따라 시장은 병원, 외래 수술 센터, 기타로 분류됩니다.

지역별로는 북미(미국, 캐나다, 멕시코), 유럽(독일, 프랑스, 영국, 이탈리아, 스페인, 기타), 아시아태평양(일본, 중국, 호주, 호주, 인도, 한국, 기타), 중남미/중동/아프리카(브라질, 남아프리카공화국, 사우디아라비아, 기타)로 분석 분석됩니다. 이 시장에서 활동하는 주요 기업으로는 Arthrex, Inc, Stryker Corporation, ConMed Corporation, GPC Medical Ltd, Johnson & Johnson, Star Sports Medicine Co, Sironixmedtech, Osteocare Medical Pvt Ltd, Biotek, Karl Storz GmbH & Co.KG가 있습니다.

목차

제1장 서론

제2장 주요 요약

제3장 시장 개요

• 시장 정의와 범위
• 주요 조사 결과
  • 영향요인
  • 주요 투자 기회
• Porter's Five Forces 분석
• 시장 역학
  • 성장 촉진요인
    • 최소침습 수술에 대한 수요 증가
    • 관절경 기기의 기술적 진보
    • 견관절 손상 증가
  • 성장 억제요인
    • 숙련된 외과의의 부족
    • 견관절경 검사 관련 고비용
  • 기회
    • 신흥국의 유리한 기회

제4장 견관절경 검사 시장 : 제품 유형별

• 개요
• 관절경
• 파워 셰이버 시스템
• 견관절경 임플란트
• 관절경 시스템
• 기타

제5장 견관절경 검사 시장 : 증상별

• 개요
• 회전근개 파열
• 견관절 불안정증 또는 탈구
• 오십견
• 어깨 충돌 증후군
• 기타

제6장 견관절경 검사 시장 : 최종사용자별

• 개요
• 병원
• 외래 수술 센터
• 기타

제7장 견관절경 검사 시장 : 지역별

• 개요
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인
  • 기타
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 기타
• 라틴아메리카, 중동 및 아프리카
  • 브라질
  • 사우디아라비아
  • 남아프리카공화국
  • 기타

제8장 경쟁 상황

• 서론
• 주요 성공 전략
• 주요 10개사 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝(2022년)

제9장 기업 개요

• Arthrex, Inc.
• Biotek
• Stryker Corporation.
• ConMed Corporation
• Osteocare Medical Pvt Ltd.
• Sironixmedtech
• Star Sports Medicine Co., Ltd.
• GPC Medical Ltd.
• Johnson & Johnson
• Karl Storz GmbH & Co. KG

ksm

영문 목차

영문목차

The shoulder arthroscopy market was valued at $432.46 million in 2022 and is estimated to reach $712.12 million by 2032, exhibiting a CAGR of 5.1% from 2023 to 2032. Shoulder arthroscopy is an outpatient procedure that uses a small camera called an arthroscope to project images of the shoulder joint onto a video screen. The images are then used by the healthcare provider to diagnose the part of the shoulder that has been injured and repair it using small surgical instruments to restore shoulder's mobility. The procedure is minimally invasive and requires smaller incisions. The incision size is about the same as a keyhole. The full procedure can take anywhere from weeks to months, but patients may get discharged on the same day. Shoulder arthroscopy allows healthcare providers to treat shoulder pain that hasn't responded to other non-surgical treatments like physical therapy, medications, injections, and rest.

Arthroscopy of the shoulder can be used for the removal of inflamed tissue. Thus, it is used to treat injuries such as biceps tendon injuries, bone spurs, frozen shoulder, labrum tears, injuries to the tissue around the shoulder socket, osteoarthritis, rotator cuff tears, rotator cuff tendinitis, shoulder impingement syndrome and shoulder instability, when the shoulder joint becomes loose or dislocated. Arthroscopy surgery for the shoulder is the second largest orthopedic procedure after knee surgery. However, the most common type of arthroscopic surgery performed on the shoulder is the rotator cuff. The growth of the market is attributed to the rise in the number of procedures, which, in turn, surges the demand for equipment.

Rise in incidence of shoulder injuries, advancements in arthroscopic techniques, aging population, and preference for minimally invasive surgery, are major factors driving the growth of the shoulder arthroscopy market. One of the main causes of shoulder arthroscopic procedures is the growing incidence of injuries to the shoulder, such as rotator cuff tears and labral tears, as well as shoulder impingements. Injuries from sports, as well as the wear and tear that comes with aging, are also contributing factors to the increase in shoulder arthroscopies.

However, high procedure costs, limited access to specialized facilities and competition from alternative treatments may act as a restraint toward market growth. Arthroscopic procedures on the shoulder can be expensive, and this can discourage some patients from undergoing the procedure. It can also cause reimbursement issues for healthcare providers. This may hinder market growth to some extent.

The shoulder arthroscopy market is segmented into product type, indication, end user, and region. On the basis of product type, the market is categorized into arthroscopes, power shaver systems, arthroscopic implants, arthroscopic systems, and others. On the basis of indication, the market is divided into rotator cuff tears, shoulder instability, frozen shoulder, shoulder impingement syndrome and others. On the basis of end user, the market is classified into hospitals, ambulatory surgical centers, and others.

By region, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA). Major players that operate in the market include Arthrex, Inc., Stryker Corporation., ConMed Corporation, GPC Medical Ltd., Johnson & Johnson, Star Sports Medicine Co., Ltd., Sironixmedtech, Osteocare Medical Pvt Ltd., Biotek and Karl Storz GmbH & Co. KG.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the shoulder arthroscopy market analysis from 2022 to 2032 to identify the prevailing shoulder arthroscopy market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the shoulder arthroscopy market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global shoulder arthroscopy market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• SWOT Analysis

Key Market Segments

By End User

• Hospitals
• Ambulatory Surgical Centers
• Other

By Product Type

• Arthroscopes
• Power shaver systems
• Shoulder arthroscopic implants
• Arthroscopic systems
• Others

By Indication

• Rotator cuff tears
• Shoulder instability or dislocation
• Frozen shoulder
• Shoulder impingement syndrome
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players:

• ConMed Corporation
• Johnson & Johnson
• Sironixmedtech
• Arthrex, Inc.
• GPC Medical Ltd.
• Biotek
• Karl Storz GmbH & Co. KG
• Osteocare Medical Pvt Ltd.
• Star Sports Medicine Co., Ltd.
• Stryker Corporation.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key market segments
• 1.3. Key benefits to the stakeholders
• 1.4. Research methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter's five forces analysis
  • 3.3.1. Low bargaining power of suppliers
  • 3.3.2. Low threat of new entrants
  • 3.3.3. Low threat of substitutes
  • 3.3.4. Low intensity of rivalry
  • 3.3.5. Low bargaining power of buyers
• 3.4. Market dynamics
  • 3.4.1. Drivers
    • 3.4.1.1. Increase in the demand for minimal invasive procedures
    • 3.4.1.2. Technological advancements in arthroscopy equipment
    • 3.4.1.3. Rising incidence of shoulder injuries
  • 3.4.2. Restraints
    • 3.4.2.1. Lack of skilled surgeons
    • 3.4.2.2. High costs associated with shoulder arthroscopy
  • 3.4.3. Opportunities
    • 3.4.3.1. Lucrative opportunities in emerging economies

CHAPTER 4: SHOULDER ARTHROSCOPY MARKET, BY PRODUCT TYPE

• 4.1. Overview
  • 4.1.1. Market size and forecast
• 4.2. Arthroscopes
  • 4.2.1. Key market trends, growth factors and opportunities
  • 4.2.2. Market size and forecast, by region
  • 4.2.3. Market share analysis by country
• 4.3. Power shaver systems
  • 4.3.1. Key market trends, growth factors and opportunities
  • 4.3.2. Market size and forecast, by region
  • 4.3.3. Market share analysis by country
• 4.4. Shoulder arthroscopic implants
  • 4.4.1. Key market trends, growth factors and opportunities
  • 4.4.2. Market size and forecast, by region
  • 4.4.3. Market share analysis by country
• 4.5. Arthroscopic systems
  • 4.5.1. Key market trends, growth factors and opportunities
  • 4.5.2. Market size and forecast, by region
  • 4.5.3. Market share analysis by country
• 4.6. Others
  • 4.6.1. Key market trends, growth factors and opportunities
  • 4.6.2. Market size and forecast, by region
  • 4.6.3. Market share analysis by country

CHAPTER 5: SHOULDER ARTHROSCOPY MARKET, BY INDICATION

• 5.1. Overview
  • 5.1.1. Market size and forecast
• 5.2. Rotator cuff tears
  • 5.2.1. Key market trends, growth factors and opportunities
  • 5.2.2. Market size and forecast, by region
  • 5.2.3. Market share analysis by country
• 5.3. Shoulder instability or dislocation
  • 5.3.1. Key market trends, growth factors and opportunities
  • 5.3.2. Market size and forecast, by region
  • 5.3.3. Market share analysis by country
• 5.4. Frozen shoulder
  • 5.4.1. Key market trends, growth factors and opportunities
  • 5.4.2. Market size and forecast, by region
  • 5.4.3. Market share analysis by country
• 5.5. Shoulder impingement syndrome
  • 5.5.1. Key market trends, growth factors and opportunities
  • 5.5.2. Market size and forecast, by region
  • 5.5.3. Market share analysis by country
• 5.6. Others
  • 5.6.1. Key market trends, growth factors and opportunities
  • 5.6.2. Market size and forecast, by region
  • 5.6.3. Market share analysis by country

CHAPTER 6: SHOULDER ARTHROSCOPY MARKET, BY END USER

• 6.1. Overview
  • 6.1.1. Market size and forecast
• 6.2. Hospitals
  • 6.2.1. Key market trends, growth factors and opportunities
  • 6.2.2. Market size and forecast, by region
  • 6.2.3. Market share analysis by country
• 6.3. Ambulatory Surgical Centers
  • 6.3.1. Key market trends, growth factors and opportunities
  • 6.3.2. Market size and forecast, by region
  • 6.3.3. Market share analysis by country
• 6.4. Other
  • 6.4.1. Key market trends, growth factors and opportunities
  • 6.4.2. Market size and forecast, by region
  • 6.4.3. Market share analysis by country

CHAPTER 7: SHOULDER ARTHROSCOPY MARKET, BY REGION

• 7.1. Overview
  • 7.1.1. Market size and forecast By Region
• 7.2. North America
  • 7.2.1. Key market trends, growth factors and opportunities
  • 7.2.2. Market size and forecast, by Product Type
  • 7.2.3. Market size and forecast, by Indication
  • 7.2.4. Market size and forecast, by End User
  • 7.2.5. Market size and forecast, by country
    • 7.2.5.1. U.S.
    • 7.2.5.1.1. Market size and forecast, by Product Type
    • 7.2.5.1.2. Market size and forecast, by Indication
    • 7.2.5.1.3. Market size and forecast, by End User
    • 7.2.5.2. Canada
    • 7.2.5.2.1. Market size and forecast, by Product Type
    • 7.2.5.2.2. Market size and forecast, by Indication
    • 7.2.5.2.3. Market size and forecast, by End User
    • 7.2.5.3. Mexico
    • 7.2.5.3.1. Market size and forecast, by Product Type
    • 7.2.5.3.2. Market size and forecast, by Indication
    • 7.2.5.3.3. Market size and forecast, by End User
• 7.3. Europe
  • 7.3.1. Key market trends, growth factors and opportunities
  • 7.3.2. Market size and forecast, by Product Type
  • 7.3.3. Market size and forecast, by Indication
  • 7.3.4. Market size and forecast, by End User
  • 7.3.5. Market size and forecast, by country
    • 7.3.5.1. Germany
    • 7.3.5.1.1. Market size and forecast, by Product Type
    • 7.3.5.1.2. Market size and forecast, by Indication
    • 7.3.5.1.3. Market size and forecast, by End User
    • 7.3.5.2. France
    • 7.3.5.2.1. Market size and forecast, by Product Type
    • 7.3.5.2.2. Market size and forecast, by Indication
    • 7.3.5.2.3. Market size and forecast, by End User
    • 7.3.5.3. UK
    • 7.3.5.3.1. Market size and forecast, by Product Type
    • 7.3.5.3.2. Market size and forecast, by Indication
    • 7.3.5.3.3. Market size and forecast, by End User
    • 7.3.5.4. Italy
    • 7.3.5.4.1. Market size and forecast, by Product Type
    • 7.3.5.4.2. Market size and forecast, by Indication
    • 7.3.5.4.3. Market size and forecast, by End User
    • 7.3.5.5. Spain
    • 7.3.5.5.1. Market size and forecast, by Product Type
    • 7.3.5.5.2. Market size and forecast, by Indication
    • 7.3.5.5.3. Market size and forecast, by End User
    • 7.3.5.6. Rest of Europe
    • 7.3.5.6.1. Market size and forecast, by Product Type
    • 7.3.5.6.2. Market size and forecast, by Indication
    • 7.3.5.6.3. Market size and forecast, by End User
• 7.4. Asia-Pacific
  • 7.4.1. Key market trends, growth factors and opportunities
  • 7.4.2. Market size and forecast, by Product Type
  • 7.4.3. Market size and forecast, by Indication
  • 7.4.4. Market size and forecast, by End User
  • 7.4.5. Market size and forecast, by country
    • 7.4.5.1. Japan
    • 7.4.5.1.1. Market size and forecast, by Product Type
    • 7.4.5.1.2. Market size and forecast, by Indication
    • 7.4.5.1.3. Market size and forecast, by End User
    • 7.4.5.2. China
    • 7.4.5.2.1. Market size and forecast, by Product Type
    • 7.4.5.2.2. Market size and forecast, by Indication
    • 7.4.5.2.3. Market size and forecast, by End User
    • 7.4.5.3. India
    • 7.4.5.3.1. Market size and forecast, by Product Type
    • 7.4.5.3.2. Market size and forecast, by Indication
    • 7.4.5.3.3. Market size and forecast, by End User
    • 7.4.5.4. Australia
    • 7.4.5.4.1. Market size and forecast, by Product Type
    • 7.4.5.4.2. Market size and forecast, by Indication
    • 7.4.5.4.3. Market size and forecast, by End User
    • 7.4.5.5. South Korea
    • 7.4.5.5.1. Market size and forecast, by Product Type
    • 7.4.5.5.2. Market size and forecast, by Indication
    • 7.4.5.5.3. Market size and forecast, by End User
    • 7.4.5.6. Rest of Asia-Pacific
    • 7.4.5.6.1. Market size and forecast, by Product Type
    • 7.4.5.6.2. Market size and forecast, by Indication
    • 7.4.5.6.3. Market size and forecast, by End User
• 7.5. LAMEA
  • 7.5.1. Key market trends, growth factors and opportunities
  • 7.5.2. Market size and forecast, by Product Type
  • 7.5.3. Market size and forecast, by Indication
  • 7.5.4. Market size and forecast, by End User
  • 7.5.5. Market size and forecast, by country
    • 7.5.5.1. Brazil
    • 7.5.5.1.1. Market size and forecast, by Product Type
    • 7.5.5.1.2. Market size and forecast, by Indication
    • 7.5.5.1.3. Market size and forecast, by End User
    • 7.5.5.2. Saudi Arabia
    • 7.5.5.2.1. Market size and forecast, by Product Type
    • 7.5.5.2.2. Market size and forecast, by Indication
    • 7.5.5.2.3. Market size and forecast, by End User
    • 7.5.5.3. South Africa
    • 7.5.5.3.1. Market size and forecast, by Product Type
    • 7.5.5.3.2. Market size and forecast, by Indication
    • 7.5.5.3.3. Market size and forecast, by End User
    • 7.5.5.4. Rest of LAMEA
    • 7.5.5.4.1. Market size and forecast, by Product Type
    • 7.5.5.4.2. Market size and forecast, by Indication
    • 7.5.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top winning strategies
• 8.3. Product mapping of top 10 player
• 8.4. Competitive dashboard
• 8.5. Competitive heatmap
• 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

• 9.1. Arthrex, Inc.
  • 9.1.1. Company overview
  • 9.1.2. Key executives
  • 9.1.3. Company snapshot
  • 9.1.4. Operating business segments
  • 9.1.5. Product portfolio
• 9.2. Biotek
  • 9.2.1. Company overview
  • 9.2.2. Key executives
  • 9.2.3. Company snapshot
  • 9.2.4. Operating business segments
  • 9.2.5. Product portfolio
• 9.3. Stryker Corporation.
  • 9.3.1. Company overview
  • 9.3.2. Key executives
  • 9.3.3. Company snapshot
  • 9.3.4. Operating business segments
  • 9.3.5. Product portfolio
  • 9.3.6. Business performance
  • 9.3.7. Key strategic moves and developments
• 9.4. ConMed Corporation
  • 9.4.1. Company overview
  • 9.4.2. Key executives
  • 9.4.3. Company snapshot
  • 9.4.4. Operating business segments
  • 9.4.5. Product portfolio
  • 9.4.6. Business performance
• 9.5. Osteocare Medical Pvt Ltd.
  • 9.5.1. Company overview
  • 9.5.2. Key executives
  • 9.5.3. Company snapshot
  • 9.5.4. Operating business segments
  • 9.5.5. Product portfolio
• 9.6. Sironixmedtech
  • 9.6.1. Company overview
  • 9.6.2. Key executives
  • 9.6.3. Company snapshot
  • 9.6.4. Operating business segments
  • 9.6.5. Product portfolio
• 9.7. Star Sports Medicine Co., Ltd.
  • 9.7.1. Company overview
  • 9.7.2. Key executives
  • 9.7.3. Company snapshot
  • 9.7.4. Operating business segments
  • 9.7.5. Product portfolio
• 9.8. GPC Medical Ltd.
  • 9.8.1. Company overview
  • 9.8.2. Key executives
  • 9.8.3. Company snapshot
  • 9.8.4. Operating business segments
  • 9.8.5. Product portfolio
• 9.9. Johnson & Johnson
  • 9.9.1. Company overview
  • 9.9.2. Key executives
  • 9.9.3. Company snapshot
  • 9.9.4. Operating business segments
  • 9.9.5. Product portfolio
  • 9.9.6. Business performance
• 9.10. Karl Storz GmbH & Co. KG
  • 9.10.1. Company overview
  • 9.10.2. Key executives
  • 9.10.3. Company snapshot
  • 9.10.4. Operating business segments
  • 9.10.5. Product portfolio

관련자료